This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
broker-rating: Archive
Is Wix.com (WIX) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Wix.com (WIX) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
WIXNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in Teradyne (TER): Read This Before Placing a Bet
by Zacks Equity Research
The average brokerage recommendation (ABR) for Teradyne (TER) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
TERPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Should You Invest in PPL (PPL) Based on Bullish Wall Street Views?
by Zacks Equity Research
The average brokerage recommendation (ABR) for PPL (PPL) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
PPLNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in Fiverr (FVRR): Read This Before Placing a Bet
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Fiverr (FVRR). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
FVRRNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is Sony (SONY) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Sony (SONY). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
SONYNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is Sweetgreen (SG) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Sweetgreen (SG) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
SGNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in Nice (NICE) Based on Wall Street's Bullish Views?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Nice (NICE) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
NICENegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Look Bullish on AudioEye (AEYE): Should You Buy?
by Zacks Equity Research
The average brokerage recommendation (ABR) for AudioEye (AEYE) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
AEYEPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Boston Scientific (BSX) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Boston Scientific (BSX) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
BSXPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Look Bullish on Oracle (ORCL): Should You Buy?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Oracle (ORCL) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
ORCLPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in Pinterest (PINS): Read This Before Placing a Bet
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Pinterest (PINS) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
PINSPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is Walmart (WMT) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Walmart (WMT) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
WMTNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Think Ares Capital (ARCC) Is a Good Investment: Is It?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Ares Capital (ARCC) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
ARCCPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts See Okta (OKTA) as a Buy: Should You Invest?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Okta (OKTA) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
OKTAPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About Chewy (CHWY): Should You Buy?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Chewy (CHWY) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
CHWYPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in Exxon (XOM): Read This Before Placing a Bet
by Zacks Equity Research
The average brokerage recommendation (ABR) for Exxon (XOM) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
XOMNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Interactive Brokers (IBKR) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Interactive Brokers (IBKR) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
IBKRPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About Roku (ROKU): Should You Buy?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Roku (ROKU) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
ROKUPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is Spotify (SPOT) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Spotify (SPOT) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
SPOTPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in UPS (UPS): Read This Before Placing a Bet
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in UPS (UPS). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
UPSNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in Constellation Energy Corporation (CEG): Read This Before Placing a Bet
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Constellation Energy Corporation (CEG). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
CEGPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in Arch Capital (ACGL): Read This Before Placing a Bet
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Arch Capital (ACGL) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
ACGLNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is Deere (DE) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Deere (DE) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
DENegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is Carvana (CVNA) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Carvana (CVNA) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
CVNAPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Should You Invest in Vital Farms (VITL) Based on Bullish Wall Street Views?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Vital Farms (VITL) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
VITLNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth